Anti-Mouse CD226 (DNAM-1) In Vivo Antibody - Ultra Low Endotoxin
Introducing the Anti-Mouse CD226 (DNAM-1) In Vivo Antibody - Ultra Low Endotoxin from Assay Genie, a premium monoclonal antibody meticulously engineered for in vivo applications. This antibody specifically targets the CD226 (DNAM-1) protein, essential in immune regulation and cellular adhesion, making it a valuable tool for research in immunology, oncology, and related disciplines. With a mouse IgG2a isotype, it guarantees exceptional purity and ultra-low endotoxin levels (<0.01 EU/μg), suitable for ELISA, flow cytometry, immunohistochemistry, and other sensitive assays. Available in varying quantities, it is compounded in a phosphate-buffered saline to ensure maximum stability and effectiveness.
Elevate the accuracy and reliability of your research with this superior antibody. CD226 (DNAM-1) is an immunoglobulin-like glycoprotein expressed on the surface of a range of immune cells, including T cells, natural killer (NK) cells, monocytes, and a subset of B cells. It plays a pivotal role in the activation and adhesion of T cells and NK cells, contributing to immune surveillance and the destruction of tumor cells. Enhance your understanding of immune response mechanisms with the Anti-Mouse CD226 (DNAM-1) In Vivo Antibody from Assay Genie.
Product Name:
Anti-Mouse CD226 (DNAM-1) In Vivo Antibody - Ultra Low Endotoxin
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Endotoxin Level:
<0.5 EU/mg as determined by the LAL method
Purity:
≥98% monomer by analytical SEC â‹… >95% by SDS Page
Product Preparation:
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Applications:
FC, In Vivo
Reactivity:
Mouse
Host Species:
Rat
Specificity:
Clone 480.1 activity is directed against murine CD226 (DNAM-1; PTA-1).
Antigen Distribution:
mCD226 is expressed on the surface of differentiated Th1 cells, CD8+ T cells, subsets of naïve CD11b+ macrophages and NK cells, and activated CD4+ cells.
Immunogen:
Th1 polarized T cell clones
Concentration:
≥ 5.0 mg/ml
Endotoxin Level:
<0.5 EU/mg as determined by the LAL method
Formulation:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Purity:
≥98% monomer by analytical SEC â‹… >95% by SDS Page
Preparation:
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -70°C. Avoid Repeated Freeze Thaw Cycles.
Murine (m) CD226 (DNAM-1; PTA1) is an adhesion molecule involved in intercellular adhesion, lymphocyte signalling, cytotoxicity, and lymphokine secretion mediated by cytotoxic T-lymphocyte and NK cells (Uniprot Q8K4F0)1. mCD226 is also essential for NK-mediated killing of immature dendritic cells2 and acts as an important costimulatory molecule in Th1 cell activation and effector function3.
CD226 binds to PVR (CD155) via its N-terminal Ig-like domain2 and with cell surface receptor NECTIN2 (CD112)1. Based on its similarity to human CD226 (Uniprot Q15762), mCD226 likely competes with PVRIG for NECTIN2 binding.
mCD226 is specifically expressed on the surface of differentiated Th1 cells but not Th2 or Th0 cells3. mCD226 expression is enhanced by Th1 differentiation but down-regulated upon Th2 polarization. In vivo treatment with anti-CD226 (clone 10E5) inhibits T cell activation and delays the onset and reduces the severity of Th1-mediated autoimmune disease. Additionally, mCD226 is constitutively expressed on CD8+ T cells, subsets of naïve CD11b+ macrophages and NK cells, and is up-regulated on activated CD4+ cells2,3. mCD226 is a marker for mature T cells2.
